
|Articles|August 14, 2012
Individualized therapy - The modern standard in wet AMD care
Novartis sponsored a symposium at the COPHy congress in 2012 exploring the current treatment issues surrounding wet AMD. This supplement reveals the highlights of the meeting.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
2
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
3
FLORetina 2025: Weight and PMA drive foveal maturation in preterm infants
4
From skepticism to clarity and focus: A family’s PRESBYOND experience
5















































